Published in Blood on June 01, 1968
Coagulopathy as a presenting feature of Wilms tumour. Eur J Pediatr (2004) 0.80
Acquired von Willebrand's syndrome and systemic lupus erythematosus. Proc R Soc Med (1972) 0.80
Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor. J Clin Pathol (1979) 0.79
Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus. Exp Hematol Oncol (2014) 0.77
Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus. Case Rep Hematol (2014) 0.77
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus (2015) 0.75
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Exp Hematol Oncol (2014) 0.75
Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia. Postgrad Med J (1990) 0.75
Prolonged post-operative bleeding due to an acquired von Willebrand syndrome. Postgrad Med J (1987) 0.75
Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature. Clin Case Rep (2017) 0.75
Acquired von Willebrand's disease associated with epithelial myoepithelial carcinoma of the parotid salivary gland. BMJ Case Rep (2014) 0.75
Recognition and treatment of intravascular coagulation. J Pediatr (1969) 2.35
A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer (1972) 2.25
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med (1993) 2.09
Fatalities during remission of childhood leukemia. Blood (1972) 2.08
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med (1990) 2.05
Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med (1993) 1.99
Prevention of central nervous system leukemia by irradiation. Cancer (1973) 1.96
A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med (1979) 1.64
Cessation of therapy during complete remission of childhood acute lymphocytic leukemia. N Engl J Med (1974) 1.55
Osteosarcoma: good news despite crude tools. J Clin Oncol (1992) 1.49
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42
Von Willebrand's disease: a comparative study of diagnostic tests. J Pediatr (1968) 1.39
Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer (1975) 1.22
Images of numbers, or "When 98 is upper left and 6 sky blue". Cognition (1992) 1.21
Comparison of two methods of preventing central nervous system leukemia. Blood (1973) 1.19
A semiautomatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med (1967) 1.18
Meningococcemia associated with intravascular coagulation. Pediatrics (1967) 1.17
Blood coagulation in thyroid dysfunction. N Engl J Med (1965) 1.16
A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID). Blood (1984) 1.15
Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med (1973) 1.13
X-linked lymphoproliferative syndrome registry report. J Pediatr (1980) 1.13
Therapy of localized and regional lymphosarcoma of childhood. Cancer (1971) 1.11
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet (1984) 1.10
Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics (1981) 1.08
Childhood acute lymphocytic leukemia: study VIII. Cancer (1978) 1.07
The current status of the treatment of childhood acute lymphoblastic leukemia. Cancer Treat Rev (1976) 1.07
Response to combination therapy after relapse in childhood acute lymphocytic leukemia. Cancer (1972) 1.06
Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency. Pediatr Emerg Care (1994) 1.04
Combined modality therapy of acute lymphocytic leukemia. Cancer (1975) 1.04
The treatment of acute lymphoblastic leukaemia. Br J Haematol (1980) 1.01
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res (1981) 1.01
Five years after central nervous system irradiation of children with leukemia. Int J Radiat Oncol Biol Phys (1976) 1.00
Thrombopoiesis. Semin Hematol (1967) 0.98
Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer (1975) 0.97
Fletcher factor deficiency: family study and detection. Blood (1974) 0.97
The management of bleeding in hemophilia. Adv Pediatr (1969) 0.96
Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol (1980) 0.95
Absence of coagulation abnormalities in children with cyanotic congenital heart-disease. Lancet (1968) 0.94
Late mortality in childhood cancer: two excellent studies bring good news tempered by room for improvement. J Clin Oncol (2001) 0.93
Studies of cross-reactivity of acquired factor VIII inhibitor activity in hemophilic plasma. Thromb Diath Haemorrh (1967) 0.93
Megakaryocytopoiesis in experimental iron deficiency anemia. Blood (1974) 0.93
Seizures in childhood lymphoblastic leukaemia patients. Lancet (1984) 0.93
Platelet production in experimental iron deficiency anemia. Blood (1973) 0.92
Understanding academic medical centers: Simone's Maxims. Clin Cancer Res (1999) 0.92
Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions. Am J Hematol (1984) 0.92
The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol (1985) 0.91
Acute lymphocytic leukemia in children. Cancer (1975) 0.89
Factors that influence haematological remission duration in acute lymphocytic leukaemia. Br J Haematol (1976) 0.88
Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment. Blood (1977) 0.88
Central nervous system leukemia in children with acute nonlymphoblastic leukemia. Blood (1985) 0.88
Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. Blood (1977) 0.88
Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X. Leukemia (1992) 0.88
Treatment of hemophilia with glycine-precipitated factor 8. N Engl J Med (1966) 0.87
Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure. Cancer (1971) 0.87
Neuraminidase-induced thrombocytopenia in rats. Br J Haematol (1972) 0.87
Early treatment of hemophilic hemarthroses with minimal dose of new factor 8 concentrate. J Pediatr (1974) 0.86
Mild homozygous beta-thalassemia. Further evidence for the heterogeneity of beta-thalassemia genes. Ann Intern Med (1966) 0.86
Serial studies in von Willebrand's disease: variability versus "variants". Blood (1980) 0.86
Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. J Pediatr (1970) 0.85
Fibrinolytic and hemostatic changes during and after maximal exercise in males. J Appl Physiol (1976) 0.85
The relationship of anemia and thrombocytosis. J Lab Clin Med (1974) 0.83
Hazards of prothrombin-complex concentrates in treatment of hemophilia. N Engl J Med (1981) 0.83
Childhood leukemia as a model for cancer research: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1979) 0.83
Editorial: Preventive central-nervous-system therapy in acute leukemia. N Engl J Med (1973) 0.83
Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome. Leuk Res (1985) 0.83
Acute nonlymphocytic leukemia in 171 children. Med Pediatr Oncol (1976) 0.82
The evolution of cancer care for children and adults. J Clin Oncol (1998) 0.82
The factor VIII abnormality in severe von Willebrand's disease. N Engl J Med (1979) 0.82
Management of childhood leukemia. Postgrad Med (1974) 0.81
Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia. Blood (1980) 0.81
Treatment of meningeal leukemia. J Clin Oncol (1984) 0.81
Three to ten years after cessation of therapy in children with leukemia. Cancer (1978) 0.80
Response of intracerebral Gardner lymphoma to guinea pig L-asparaginase and Escherichia coli L-asparaginase. Proc Soc Exp Biol Med (1966) 0.80
The survivors of childhood solid tumors. Pediatr Clin North Am (1991) 0.80
The pharmacokinetics of recombinant factor VIII. The rFactor VIII Clinical Trial Group. Semin Hematol (1991) 0.80
Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the Factor VIII and von Willebrand Factor Subcommittee. Thromb Haemost (1985) 0.80
Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia. Cancer (1978) 0.80
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood (1982) 0.79
The treatment of neuroblastoma. J Clin Oncol (1984) 0.79
Progression of methotrexate-induced leukoencephalopathy in children with leukemia. Med Pediatr Oncol (1981) 0.79
Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors. J Pediatr (1976) 0.79
Quantitative aspects of blood coagulation in the generalized Shwartzman reaction. II. Effect of cortisone. Pediatr Res (1967) 0.79
von Willebrand factor multimer analysis using a sensitive peroxidase staining method. Thromb Haemost (1989) 0.79
Outlook for acute lymphocytic leukemia in children in 1982. Annu Rev Med (1981) 0.79
Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine. J Clin Oncol (1983) 0.79
Acquired von Willebrand's syndrome with lupus-like serology. Am J Pediatr Hematol Oncol (1989) 0.78
Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens. Am J Dis Child (1977) 0.78
Generalized Shwartzman reaction: role of the granulocyte in intravascular coagulation and renal cortical necrosis. Br J Haematol (1969) 0.78
Factor-8 (antihaemophilic factor) activity in sickle-cell anaemia. Br J Haematol (1967) 0.78
Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. Leuk Res (1982) 0.78
Age and human immunodeficiency virus infection in persons with hemophilia in California. Am J Public Health (1990) 0.78